Callos Andrew
SEC CIK 1852129 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | EVP, Chief Commercial Off | 68.6K | — | $18.98M | 62 | 2022-02-16 | 2026-08-31 |
Most active insiders at CYTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| 2 | Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| 3 | Lee Sung | EVP, CFO | — | $5.70M |
| 4 | Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| 5 | Kaye Edward M. MD | Dir | — | $3.21M |
| 6 | HENDERSON JOHN T | Dir | — | $2.08M |
| 7 | WIERENGA WENDELL | Dir | — | $1.88M |
| 8 | PARSHALL B LYNNE | Dir | — | $1.36M |
| 9 | Landry Robert E | Dir | — | $146.8K |
| 10 | Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 62
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-31 16:57 | 2026-08-31 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +10.0K | 68.6K | +17% | +$232.6K |
| DT | 2026-08-31 16:57 | 2026-08-31 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $70.24 | -10.0K | 58.6K | -15% | -$702.4K |
| DT | 2026-07-30 16:26 | 2026-07-30 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +14.0K | 72.6K | +24% | +$325.6K |
| DT | 2026-07-30 16:26 | 2026-07-30 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $79.88 | -14.0K | 58.6K | -19% | -$1.12M |
| DT | 2026-07-02 17:19 | 2026-07-01 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 73.6K | +26% | +$348.9K |
| DT | 2026-07-02 17:19 | 2026-07-01 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $85.80 | -15.0K | 58.6K | -20% | -$1.29M |
| DT | 2026-06-01 18:51 | 2026-06-01 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 73.6K | +26% | +$348.9K |
| DT | 2026-06-01 18:51 | 2026-06-01 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $74.08 | -15.0K | 58.6K | -20% | -$1.11M |
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $39.13 | +11.3K | 69.9K | +19% | +$443.5K |
| DT | 2026-05-05 16:11 | 2026-05-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $77.25 | -11.3K | 58.6K | -16% | -$875.5K |
| DT | 2026-05-04 16:01 | 2026-05-01 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +15.9K | 74.4K | +27% | +$596.7K |
| DT | 2026-05-04 16:01 | 2026-05-01 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $65.00 | -15.9K | 58.6K | -21% | -$1.03M |
| DT | 2026-04-30 16:22 | 2026-04-30 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 73.6K | +26% | +$348.9K |
| DT | 2026-04-30 16:22 | 2026-04-30 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $63.26 | -15.0K | 58.6K | -20% | -$948.9K |
| T | 2026-04-15 17:29 | 2026-04-15 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $66.02 | -7,449 | 58.6K | -11% | -$491.8K |
| 2026-03-31 | 2026-03-31 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $65.00 | -3,639 | 66.0K | -5% | -$236.5K | |
| 2026-03-18 | 2026-03-18 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $62.07 | -1,930 | 78.2K | -2% | -$119.8K | |
| M | 2026-03-18 | 2026-03-17 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $62.15 | -8,542 | 71.6K | -11% | -$530.9K |
| DM | 2026-03-17 | 2026-03-15 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +34.0K | 68.5K | +98% | $0 |
| 2026-03-16 | 2026-03-16 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $61.03 | -1,709 | 46.1K | -4% | -$104.3K | |
| 2026-03-10 | 2026-03-09 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $60.72 | -2,582 | 47.9K | -5% | -$156.8K | |
| DM | 2026-03-05 | 2026-03-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $29.97 | +26.0K | 76.4K | +52% | +$779.3K |
| DM | 2026-03-05 | 2026-03-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $61.87 | -26.0K | 61.4K | -30% | -$1.61M |
| D | 2026-03-02 | 2026-03-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $61.62 | -886 | 50.4K | -2% | -$54.6K |
| D | 2026-03-02 | 2026-03-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +886 | 51.3K | +2% | +$33.3K |
| D | 2026-02-05 | 2026-02-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $61.93 | -15.0K | 50.4K | -23% | -$929.0K |
| D | 2026-02-05 | 2026-02-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 65.4K | +30% | +$348.9K |
| D | 2026-02-02 | 2026-02-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +886 | 51.3K | +2% | +$33.3K |
| D | 2026-02-02 | 2026-02-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $62.10 | -886 | 50.4K | -2% | -$55.0K |
| D | 2026-01-05 | 2026-01-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +15.0K | 65.4K | +30% | +$348.9K |
| D | 2026-01-05 | 2026-01-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $60.28 | -15.0K | 50.4K | -23% | -$904.2K |
| DM | 2026-01-02 | 2026-01-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $62.62 | -1,798 | 50.4K | -3% | -$112.6K |
| D | 2026-01-02 | 2026-01-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +885 | 51.3K | +2% | +$33.3K |
| 2025-12-30 | 2025-12-29 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $62.44 | -1,809 | 51.4K | -3% | -$113.0K | |
| M | 2025-12-29 | 2025-12-22 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,177 | 52.2K | +6% | $0 |
| 2025-12-29 | 2025-12-22 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $62.72 | -675 | 53.2K | -1% | -$42.3K | |
| D | 2025-12-08 | 2025-12-08 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $65.96 | -1,042 | 50.7K | -2% | -$68.7K |
| D | 2025-12-08 | 2025-12-08 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $39.13 | +1,042 | 51.7K | +2% | +$40.8K |
| 2025-12-05 | 2025-12-03 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $65.02 | -1,368 | 50.7K | -3% | -$88.9K | |
| DM | 2025-12-05 | 2025-12-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $33.84 | +52.5K | 92.5K | +131% | +$1.78M |
| D | 2025-12-05 | 2025-12-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $65.95 | -52.5K | 50.7K | -51% | -$3.46M |
| 2025-06-05 | 2025-06-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $32.04 | -8,659 | 52.0K | -14% | -$277.4K | |
| 2025-05-05 | 2025-05-05 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $36.68 | -4,002 | 60.7K | -6% | -$146.8K | |
| 2025-04-07 | 2025-04-07 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $35.78 | -2,886 | 64.7K | -4% | -$103.3K | |
| D | 2025-03-18 | 2025-03-14 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +32.7K | 70.3K | +87% | $0 |
| 2025-03-17 | 2025-03-17 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $44.38 | -2,775 | 34.9K | -7% | -$123.2K | |
| D | 2025-03-17 | 2025-03-17 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +20.9K | 58.6K | +55% | +$486.1K |
| D | 2025-03-17 | 2025-03-17 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $45.14 | -20.9K | 37.7K | -36% | -$943.4K |
| D | 2025-03-14 | 2025-03-14 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $45.00 | -100 | 37.7K | -0.3% | -$4,500 |
| D | 2025-03-14 | 2025-03-14 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $23.26 | +100 | 37.8K | +0.3% | +$2,326 |
| 2025-03-13 | 2025-03-13 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $43.62 | -26.8K | 37.7K | -42% | -$1.17M | |
| 2025-03-07 | 2025-03-06 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $43.27 | -3,341 | 64.4K | -5% | -$144.6K | |
| 2025-03-05 | 2025-03-03 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | S - Sale | $42.88 | -1,114 | 67.8K | -2% | -$47.8K | |
| 2024-12-05 | 2024-12-03 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $51.51 | -1,351 | 65.7K | -2% | -$69.6K | |
| M | 2024-12-05 | 2024-12-03 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +6,353 | 68.9K | +10% | $0 |
| D | 2024-03-18 | 2024-03-14 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +16.9K | 63.9K | +36% | $0 |
| M | 2024-03-07 | 2024-03-04+ | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $67.12 | -7,305 | 52.0K | -12% | -$490.3K |
| D | 2023-03-07 | 2023-03-06 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +30.0K | 53.7K | +127% | $0 |
| 2023-03-03 | 2023-03-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $39.60 | -2,202 | 23.7K | -9% | -$87.2K | |
| 2023-02-17 | 2023-02-16 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $44.13 | -969 | 25.9K | -4% | -$42.8K | |
| D | 2022-03-03 | 2022-03-02 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +20.0K | 26.2K | +323% | $0 |
| M | 2022-02-17 | 2022-02-16 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +5,044 | 3,071 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations